The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model
BackgroundCefoperazone/sulbactam (CPZ/SAM) is an important treatment option for infections caused by multidrug-resistant gram-negative bacteria. However, it is associated with an increased risk of coagulation disorders (CD) and causes severe bleeding in some instances. Early identification of risk f...
Saved in:
Main Authors: | Changjing Xu, Junlong Zhu, Kun Tu, Hui Tang, Xinxin Zhou, Qiuyu Li, Kun Chen, Xuping Yang, Yilan Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1505653/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valine potentiates cefoperazone-sulbactam to kill methicillin-resistant Staphylococcus aureus
by: Shao-hua Li, et al.
Published: (2025-01-01) -
Evaluating the in vitro activity of cefoperazone-sulbactam against Gram negative pathogens in blood stream infections using automated systems
by: Uksim Qadri, et al.
Published: (2024-12-01) -
Bacteriological profile and antimicrobial sensitivity pattern of wound infections in burns ward of a tertiary care hospital: a retro-prospective study
by: Anvesh Anand Gaonkar, et al.
Published: (2024-12-01) -
A green approach to the analysis of co-administered ampicillin/sulbactam and paracetamol in human urine
by: SELIM BASMA M., et al.
Published: (2022-06-01) -
Seizure aggravation by ampicillin/sulbactam in an elderly patient with status epilepticus
by: Kaoru Obata, et al.
Published: (2025-01-01)